Researchers discover new HIV vaccine-related tool

February 23, 2012, Simon Fraser University
SFU health scientist Ralph Pantophlet takes a close up look at a bacterium that he and his colleagues have discovered could help our immune system eliminate HIV.

(Medical Xpress) -- A new discovery involving two Simon Fraser University scientists could lead to a little known and benign bacterium becoming a vital new tool in the development of a vaccine against human immunodeficiency virus (HIV).

Ralph Pantophlet, a Faculty of Health Sciences assistant professor, and Kate Auyeung, his senior research assistant and lab manager at SFU, and scientists in Italy have made a breakthrough discovery about Rhizobium radiobacter.

The journal Chemistry & Biology has just published their research in its Feb. 24 issue.

The research team has discovered this harmless bacterium has on its surface sugar molecules that resemble those on the surface of .

This resemblance gives scientists a basis for developing a preventative vaccine, putting our immune system on guard against HIV.

HIV’s sugar molecules act as a cloaking device, preventing our immune system from detecting the virus until it has created several variant generations of itself.

By the time our immune system’s recognition has kicked in, weeks have elapsed, and HIV is several steps ahead of our body’s efforts to eliminate it.

Pantophlet and his colleagues believe the sugar molecules on Rhizobium radiobacter could be used to trigger our immune system to immediately recognize those on HIV, prompting more immediate awareness of the virus’ invasion.

“The irony of our discovery is not lost on us,” says Pantophlet. “We’ve found that a harmless species of a bacteria family that can cause tumours in the roots of legume plants could become a vital tool in the fight against one of the deadliest infectious diseases.”

Before Rhizobium radiobacter can become the basis of an anti-HIV vaccine, the scientists need to find a protein to which they can attach the bacterium’s sugar molecules. The protein is needed to properly trigger our ’s development of antibodies to the sugar molecules. Such antibodies would then recognize and target HIV’s sugar molecules because they resemble those on the .

This method of triggering antibodies’ development has led to the invention of successful sugar-based vaccines against diseases such as meningitis and childhood pneumonia.

“Two known proteins, tetanus toxoid and CRM197, a nontoxic recombinant variant of diphtheria toxin, are commonly used to develop these kinds of vaccines,” explains Pantophlet. “So a lot of the groundwork is there for us to be able to have a vaccine that could be tested in a lab first and then in clinical trials later on.”

Pantophlet and his colleagues are seeking grant funding from the Canadian Institutes for Health Research to continue their research.

If they get the grant, they hope to attach Rhizobium radiobacter’s to a protein and create vaccine candidates for testing within the next one to two years.

Explore further: External capsule protects gum disease-causing bacteria from immune response

More information: www.cell.com/chemistry-biology/home

Related Stories

External capsule protects gum disease-causing bacteria from immune response

November 17, 2011
(Medical Xpress) -- The capsule of Porphyromonas gingivalis, the bacterium that causes gum disease, provides stealth, boosting the bacterium’s virulence, according to a paper published in the November Infection and ...

Recognizing blood poisoning quickly

December 2, 2011
(Medical Xpress) -- Is the patient suffering from blood poisoning? To answer this question, the doctor draws a blood sample and sends it to a central laboratory for testing. This takes up valuable time, which could cost the ...

Equine herpesvirus study to unravel how virus unlocks immune system 'gate'

January 19, 2012
A Colorado State University study will look at how equine herpesvirus type 1 may compromise the immune system immediately upon entering the “gate” of a horse’s respiratory system – the airway and throat ...

New tool enhances view of muscles

January 23, 2012
Simon Fraser University associate professor James Wakeling is adding to the arsenal of increasingly sophisticated medical imaging tools with a new signal-processing method for viewing muscle activation details that have never ...

Recommended for you

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

Usage remains low for pill that can prevent HIV infection

January 8, 2018
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...

Researchers find clues to AIDS resistance in sooty mangabey genome

January 3, 2018
Peaceful co-existence, rather than war: that's how sooty mangabeys, a monkey species found in West Africa, handle infection by SIV, a relative of HIV, and avoid developing AIDS-like disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.